Monoamine oxidase inhibitors in resistant major depression: A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants
- 31 July 1993
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 28 (3), 189-197
- https://doi.org/10.1016/0165-0327(93)90104-r
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Hypnotics as concurrent medication in depression: A placebo-controlled, double-blind comparison of flunitrazepam and lormetazepam in patients with major depression, treated with a (tri) cyclic antidepressantJournal of Affective Disorders, 1993
- Brofaromine - a Selective, Reversible, and Short-Acting MAO-A Inhibitor: Review of the Pharmacological and Clinical FindingsPharmacopsychiatry, 1991
- High Dose Tranylcypromine Therapy for Refractory DepressionPharmacopsychiatry, 1989
- Treatment strategy in depressionActa Psychiatrica Scandinavica, 1988
- L-5HTP in Depression Resistant to Re-Uptake InhibitorsThe British Journal of Psychiatry, 1985
- TREATMENT OF DELUSIONAL DEPRESSION WITH TRANYLCYPROMINEJournal of Nervous & Mental Disease, 1978
- The Diagnosis of Depressive Syndromes and the Prediction of E.C.T. ResponseThe British Journal of Psychiatry, 1965
- Effects of Iproniazid in Depressive SyndromesBMJ, 1959